What We Do
The Elizabeth Glaser Pediatric AIDS Foundation seeks to end global pediatric HIV/AIDS through prevention and treatment programs, research, and advocacy
Expand high quality, evidence-based, locally sustained HIV/AIDS programs and services, as well as strengthened health systems to end HIV/AIDS among children, adolescents, and families
Advance research and innovation to prevent, treat, and end HIV/AIDS among children, adolescents, and families
Advocate for global, regional, national, and local policies and guidelines, resources, and political leadership to end HIV/AIDS among children, adolescents, and families
Since our inception in 1988, there has been a 95 percent decline in new pediatric HIV infections in the U.S., and a nearly 60 percent decline in the number of new infections in children worldwide since the year 2000.
A sizable portion of infections averted in children globally are the result of EGPAF-supported programs in countries heavily affected by the epidemic. The risk of mother-to-child transmission during pregnancy, delivery, and breastfeeding, which accounts for more than 90% of new childhood infections, can be reduced to less than 5% by providing the mother access to effective antiretroviral therapy and support services. At the end of 2015, nearly half of all children already infected with HIV worldwide were being protected from the debilitating and lethal effects of AIDS by receiving effective antiretroviral therapy. The elimination of new childhood HIV infections and AIDS remains within our reach.